Altria pays $235 million to settle Juul lawsuits

May.11.2023
Altria pays $235 million to settle Juul lawsuits
Altria Group has agreed to pay $235 million to settle lawsuits related to its investment in Juul and youth vaping.

On May 10th, according to a report from Reuters, Altria Group announced it will pay $235 million to settle at least 6,000 lawsuits accusing the company of encouraging teenage e-cigarette use by investing in Juul, a leading e-cigarette manufacturer.


This deal settled nearly all lawsuits brought against Altria by local government agencies and individuals across the United States related to Juul. Altria anticipates recording a pre-tax charge of $235 million in the second quarter of 2023 and intends to exclude this charge from adjusted earnings per share.


Sarah London, one of the lead lawyers for the plaintiff, stated in a written statement regarding the settlement that it would provide "unprecedented and truly meaningful relief for youth, parents, and government organizations nationwide.


Murray Garnick, Altria's Executive Vice President and General Counsel, recently said that the claims against Altria are unfounded. However, he believes that settling the matter would be in the best interest of the company's shareholders.


However, we believe this resolution avoids the uncertainty and costs of lengthy legal proceedings, and is in the best interests of our shareholders.


The plaintiff in the lawsuit alleges that Juul employed inappropriate methods (such as promoting flavored e-cigarettes and utilizing internet and social media campaigns) to market their products to minors, and that Altria assisted Juul's marketing efforts by allowing them to use their sales team and display their products on shelves next to Altria's own products.


Altria has announced that it has relinquished its 35% stake in Juul. As of December 2022, its stake in Juul was worth $250 million, down from the $12.8 billion it invested in 2018.


Juul has reached settlements in the majority of its cases, paying over $1 billion to 48 states and territories, as well as $1.7 billion to individual and local government entities.


Beth Wilkinson, lawyer for Altria, stated in a recent lawsuit that the company did not benefit from its investment in JUUL.


This investment of 12.8 billion dollars did not result in any returns, and Altria did not benefit from it in any way.


References:


Altria has agreed to pay $235 million in order to settle all cases related to Juul, the vaping giant in which the cigarette maker has a 35% stake. This settlement will end all lawsuits that have been filed against Altria over Juul-related issues.


This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

Philip Morris Japan Launches New TEREA “Stellar Pearl,” Featuring Mint and Yellow Citrus Notes
Philip Morris Japan Launches New TEREA “Stellar Pearl,” Featuring Mint and Yellow Citrus Notes
Philip Morris Japan announced the launch of a new TEREA heated tobacco stick for the IQOS ILUMA series, “TEREA Stellar Pearl,” featuring a crushable capsule mint profile. The product will go on sale in Japan through offline retail channels from Jan. 19 and will be rolled out on the company’s official e-commerce store from Jan. 29, priced at 580 yen (about $3.6) per pack.
Jan.14 by 2FIRSTS.ai
South Korea Signs Agreement to Recycle PMK E-Cigarette Devices via Postal System
South Korea Signs Agreement to Recycle PMK E-Cigarette Devices via Postal System
South Korea will introduce a postal-based collection system for electronic cigarette devices, allowing consumers to dispose of used devices through nationwide mailboxes or post office counters. Relevant government bodies and private partners have signed a cooperation agreement to address the lack of clear disposal standards for e-cigarette devices.
Dec.16 by 2FIRSTS.ai
Vape sellers sue to block Texas law banning e-liquids from China and other “foreign adversaries”
Vape sellers sue to block Texas law banning e-liquids from China and other “foreign adversaries”
A group of vape distributors and retailers has sued to block enforcement of a Texas law that criminalizes selling or marketing vape products containing e-liquids made wholly or partly in China or in countries designated as “foreign adversaries” by the U.S. Commerce Secretary. The plaintiffs argue the law violates the U.S. Constitution because only Congress may regulate foreign commerce.
Feb.03 by 2FIRSTS.ai
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
PMI says it submitted evidence to FDA panel backing ZYN bid for modified-risk status
Philip Morris International said it presented scientific evidence to the U.S. Food and Drug Administration’s Tobacco Products Scientific Advisory Committee to support its ZYN nicotine pouches seeking a modified risk tobacco product designation, which would allow the company to communicate to adult smokers that switching completely to ZYN could reduce the risk of multiple smoking-related diseases.
Jan.26 by 2FIRSTS.ai
2Firsts Observation | Element Vape Launches “Made in USA” Section as Product Pages Show “Assembled in USA” and “Made in USA” Labels
2Firsts Observation | Element Vape Launches “Made in USA” Section as Product Pages Show “Assembled in USA” and “Made in USA” Labels
Element Vape, a U.S. online vaping retailer, uses origin labels such as “Made in USA” and “Assembled in USA” across disposable vape product pages and a dedicated collection page, grouping items under “Made in USA Disposable Vapes,” but the platform does not disclose on its public pages the applicable standards or evidentiary basis for these different claims.
Jan.20 by 2FIRSTS.ai
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA Posts Final ZYN MRTP Materials, Sets March 4 Deadline for Public Comments
U.S. FDA has released the final batch of materials for ZYN MRTP applications and set March 4 (11:59 p.m. ET) as the deadline for public comments to be considered in the agency’s review.
Feb.03 by 2FIRSTS.ai